CIK 0001388320
- Non-accelerated filer
- Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880378336
- Phone
- +1 646-677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-14 | TRAVERSA SERGIO Director | Grant or award · Options to purchase common stock | +75,000 | $1.39 | $104K | 75,000 |
| 2016-04-15 | TRAVERSA SERGIO Director | Purchase | +1,000 | $2.02 | $2K | 3,000 |
| 2016-04-15 | TRAVERSA SERGIO Director | Grant or award · Options to purchase common stock | +75,000 | $1.99 | $149K | 75,000 |
| 2016-04-14 | TRAVERSA SERGIO Director | Purchase | +2,000 | $2.02 | $4K | 2,000 |
| 2015-02-18 | TRAVERSA SERGIO Director | Grant or award · Options to purchase common stock | +25,000 | $3.58 | $90K | 25,000 |
| 2013-08-08 | TRAVERSA SERGIO Interim CFO | Grant or award | +10,000 | $3.60 | $36K | 0 |
| 2013-08-08 | TRAVERSA SERGIO Interim CFO | Grant or award · Options to purchase common stock | +20,000 | $3.60 | $72K | 4,995 |
Page 1 of 1 · 7 trades